The global tonic-clonic seizures treatment market is poised for significant growth, with an expected compound annual growth rate (CAGR) of 6% during the forecast period from 2024 to 2032. This market growth is largely driven by increasing research and development efforts, along with the rising number of clinical trials focused on discovering novel treatments. Moreover, the introduction of...